Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Fresenius Kabi ArgentinaFresenius Kabi Argentina
VS
Teva PharmaceuticalsTeva Pharmaceuticals
Fresenius Kabi Argentina

Fresenius Kabi Argentina

undefined, Ciudad autónoma de buenos aires, Capital Federal, C1428AAI, AR

Last Update: 18/02/2026

View Profile
753/1000Fair

Como compañía global de atención médica, Fresenius Kabi está Comprometida con la Vida. Nuestros productos, tecnologías y servicios se utilizan en la terapia y el cuidado de pacientes en estado crítico y con enfermedades crónicas. Con más de 43.000 empleados y presencia ...

NAICS:325
NAICS Definition:N/A
Employees:126
Subsidiaries:38
12-month incidents
0
Known data breaches
0
Attack type number
0
Teva Pharmaceuticals

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, IL, 6944020

Last Update: 11/09/2026

View Profile
Between 800 and 849
http://www.tevapharm.com
809/1000Good

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:29,951
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Fresenius Kabi Argentina

Fresenius Kabi Argentina

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Teva Pharmaceuticals

Teva Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi Argentina in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Teva Pharmaceuticals in 2026.

Incidents

Incident History - Fresenius Kabi Argentina (X = Date, Y = Severity)

Fresenius Kabi Argentina cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Fresenius Kabi Argentina

Fresenius Kabi Argentina

Incidents
No explicit notable incidents reported.
Teva Pharmaceuticals

Teva Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced at least one data breach ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one holds the most compliance certifications ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has the most subsidiaries ?
Between Fresenius Kabi Argentina company and Teva Pharmaceuticals company, which one has the largest number of employees ?
Between Fresenius Kabi Argentina and Teva Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Fresenius Kabi Argentina and Teva Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Fresenius Kabi Argentina or Teva Pharmaceuticals ?
Which company is PCI DSS compliant - Fresenius Kabi Argentina or Teva Pharmaceuticals ?
Between Fresenius Kabi Argentina and Teva Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Fresenius Kabi Argentina and Teva Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94426
SUMMARY

A vulnerability was determined in xuxueli xxl-job up to 3.5.0. The impacted element is an unknown function of the file /jobgroup/insert. This manipulation of the argument Name causes cross site scripting. The attack can be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 3.5)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
CVSS3
Base Score: 3.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.1
CVE-2026-94425
SUMMARY

A vulnerability was found in Moore Threads MTT S80 Driver Package 340.150. The affected element is the function sub_140006F0C in the library mtdispkm64.sys of the component IOCTL Handler. The manipulation results in improper privilege management. Attacking locally is a requirement. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 8.8)
CVSS2
Base Score: 6.8
Complexity: LOW
AV:L/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
2
CVE-2026-94627
SUMMARY

vLLM Mooncake connector through 0.29.0 fails to properly manage GPU KV cache block ownership when concurrent child requests share a single transfer ID in prefill/decode disaggregated deployments. Attackers can trigger GPU memory exhaustion by submitting completion requests with multiple prompts, causing orphaned KV cache blocks to accumulate until process restart and eventually preventing legitimate requests from executing.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94626
SUMMARY

vLLM through 0.29.0 fails to validate the tp_size parameter in kv_transfer_params on OpenAI-compatible completion endpoints, allowing attackers to allocate unbounded memory. Attackers can supply arbitrary tp_size values in prefill/decode disaggregated deployments to exhaust memory and trigger kernel OOM-kill of the decode worker process.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94625
SUMMARY

vLLM through 0.29.0 contains a resource exhaustion vulnerability in MooncakeConnector where rejected prefill requests create ownerless transfer placeholders that are never reclaimed. Attackers can send rejected requests to exhaust sender task pools, causing valid requests to be delayed by up to 480 seconds while health checks continue returning success.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9